Drug Information

General Information
Drug ID
DR00591
Drug Name
Chlorprothixene
Synonyms
(3E)-3-(2-chloro-9H-thioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine; (3E)-3-(2-chlorothioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine; (3Z)-3-(2-chloro-9H-thioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine; (3Z)-3-(2-chlorothioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine; (Z)-2-Chloro-9-(omega-dimethylaminopropylidene)thioxanthene; (Z)-2-Chloro-N,N-dimethylthioxanthene-.DELTA.(sup9),(sup.gamma.)-propylamine; (Z)-2-Chloro-N,N-dimethylthioxanthene-delta(sup 9,gamma)-propylamine; (alpha.-2-Chloro-9-.omega.-dimethylamino-propylamine)thioxanthene; 2-Chloro-9-[.omega.-(dimethylamino)propylidene]thioxanthene; 2-Chloro-9-[3-(dimethylamino)propylidene]thioxanthene; 2-Chloro-N,N-dimethylthioxanthene-.delta.(sup 9), .gamma.-propylamine; 3-(2-chloro-9H-thioxanthen-9-ylidene)-N,N-dimethyl-1-propanamine; 3-(2-chloro-9H-thioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine; 3-(2-chlorothioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine; Alpha-Chlorprothixene; Chloroprothixene; Chlorprothixen; Chlorprothixene (JAN/USAN/INN); Chlorprothixene [USAN:INN:BAN:JAN]; Chlorprothixenum; Chlorprothixenum [INN-Latin]; Chlorprothixine; Chlorprotixen; Chlorprotixene; Chlorprotixine; Chlothixen; Cis-2-Chloro-9-(3-dimethylaminopropylidene)thioxanthene; Cis-Chlorprothixene; Clorprotisene; Clorprotisene [DCIT]; Clorprotixeno; Clorprotixeno [INN-Spanish]; Cloxan, Taractan, Truxal, Chlorprothixene; Iaractan; MK 184; N 714; N 714C; N-714; NCI56378; Paxyl; Rentovet; Ro 4-0403; Ro-4-0403;Trans(E)-Chlorprothixen; Tactaran; Taractan; Taractan (TN); Tarasan; Tardan; Thioxanthene-delta9,gamma-propylamine, 2-chloro-N,N-dimethyl-, (Z)-(8CI); Traquilan; Trictal; Truxal; Truxal (TN); Truxaletten; Truxil; Vetacalm; {3-[2-Chloro-thioxanthen-(9Z)-ylidene]-propyl}-dimethyl-amine
Drug Type
Small molecular drug
Therapeutic Class
Antipsychotic Agents
Structure
3D MOL 2D MOL
Formula
C18H18ClNS
Canonical SMILES
CN(C)CCC=C1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl
InChI
InChI=1S/C18H18ClNS/c1-20(2)11-5-7-14-15-6-3-4-8-17(15)21-18-10-9-13(19)12-16(14)18/h3-4,6-10,12H,5,11H2,1-2H3/b14-7-
InChIKey
WSPOMRSOLSGNFJ-AUWJEWJLSA-N
CAS Number
CAS 113-59-7
Pharmaceutical Properties Molecular Weight 315.9 Topological Polar Surface Area 28.5
Heavy Atom Count 21 Rotatable Bond Count 3
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 2
XLogP
5.2
PubChem CID
667467
PubChem SID
10154 , 103237480 , 104098333 , 104253371 , 109612796 , 109839929 , 117740987 , 124634843 , 124757488 , 125141149 , 125164292 , 134338113 , 135692269 , 137171624 , 141696535 , 14950525 , 170507547 , 176484799 , 177749223 , 179038843 , 179116620 , 187072594 , 198936237 , 210279417 , 210281740 , 225203928 , 226471863 , 226471864 , 251911945 , 251915022 , 252219919 , 26665646 , 29217891 , 47424343 , 47869779 , 48318550 , 56394950 , 57408480 , 616473 , 74621737 , 7847855 , 81093297 , 81732 , 90534681 , 9276657
ChEBI ID
ChEBI:50931
TTD Drug ID
D0B0CP

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.